Christine Brown

About the Author Christine Brown


Analysts Are Bullish on These Materials Stocks: Crown Holdings (CCK), Freeport-McMoRan (FCX)

There’s a lot to be optimistic about in the Materials sector as 2 analysts just weighed in on Crown Holdings (CCK) and Freeport-McMoRan …

Analysts Offer Insights on Technology Companies: Wix (WIX) and Spirit AeroSystems (SPR)

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Wix (WIX) and Spirit AeroSystems …

Northland Securities Keeps a Buy Rating on Brainsway (BWAY)

Northland Securities analyst Jason Wittes maintained a Buy rating on Brainsway (BWAY) today and set a price target of $15.00.

Analysts Offer Insights on Technology Companies: Remark Holdings (MARK) and Brightcove (BCOV)

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Remark Holdings (MARK) and Brightcove …

Robert W. Baird Believes Visa (V) Still Has Room to Grow

Robert W. Baird analyst David Koning maintained a Buy rating on Visa (V) on April 18 and set a price target of $275.

Leerink Partners Thinks Neovasc’s Stock is Going to Recover

In a report issued on April 16, Danielle Antalffy from Leerink Partners maintained a Buy rating on Neovasc (NVCN). The company’s shares closed …

Analysts Are Bullish on These Healthcare Stocks: Mersana Therapeutics (MRSN), AstraZeneca (AZN)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Mersana Therapeutics (MRSN), AstraZeneca (AZN) …

Analysts Are Bullish on Top Technology Stocks: Transdigm Group (TDG), Roper Technologies (ROP)

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Transdigm Group (TDG) and Roper …

Cleaves Securities Keeps a Buy Rating on Avance Gas Holding (AVACF)

In a report issued on April 18, Joakim Hannisdahl from Cleaves Securities maintained a Buy rating on Avance Gas Holding (AVACF), with a …

Alnylam Pharma (ALNY) Gets a Hold Rating from Oppenheimer

In a report released today, Leland Gershell from Oppenheimer assigned a Hold rating to Alnylam Pharma (ALNY), with a price target of $171.00.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts